Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer (Q37930972)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 13 September 2011

Language	Label	Description	Also known as
English	Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer	scientific article published on 13 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Dmitri Pchejetski

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Torsten Böhler

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Justin Stebbing

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Jonathan Waxman

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

0 references

publication date

13 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Nature Reviews Urology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

569-678

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Molecular alterations in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase: biochemical and cellular regulation and role in disease

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Role of ABCC1 in export of sphingosine-1-phosphate from mast cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Signal transduction of sphingosine-1-phosphate G protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Extracellular and Intracellular Actions of Sphingosine-1-Phosphate

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

An oncogenic role of sphingosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non–Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase transmits estrogen signaling in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3).

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Filamin A links sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 at lamellipodia to orchestrate cell migration

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Signaling and biological actions of sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

VEGF receptor expression and signaling in human bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247)

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720 (fingolimod) in renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Immunosuppressive therapy and post-transplant malignancy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Finding a way out: lymphocyte egress from lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian Cells

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Essential role for sphingosine kinases in neural and vascular development

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Delta-catenin/NPRAP (neural plakophilin-related armadillo repeat protein) interacts with and activates sphingosine kinase 1.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The mechanism of membrane targeting of human sphingosine kinase 1.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Coordinate regulation of sphingosine kinase and actin dynamics

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The localization and activity of sphingosine kinase 1 are coordinately regulated with actin cytoskeletal dynamics in macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Identification and characterization of RPK118, a novel sphingosine kinase-1-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonist-induced phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Aminoacylase 1 is a sphingosine kinase 1-interacting protein

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Deactivation of sphingosine kinase 1 by protein phosphatase 2A.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Cloning and characterization of a protein kinase A anchoring protein (AKAP)-related protein that interacts with and regulates sphingosine kinase 1 activity

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The expression of sphingosine kinase-1 in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Biologically active sphingolipids in cancer pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

An update on sphingosine-1-phosphate and other sphingolipid mediators

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Principles of bioactive lipid signalling: lessons from sphingolipids

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase, sphingosine-1-phosphate, and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase activation mediates ischemic preconditioning in murine heart

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Role of sphingosine kinase 2 in cell migration toward epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

21 January 2018

Prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

31 March 2020

Inhibition of recombinant sphingosine kinases by novel inhibitors of microbial origin, F-12509A and B-5354c.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

31 March 2020

Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

31 March 2020

Ethnic sensitivity study of fingolimod in white and Asian subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

31 March 2020

The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1α protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

31 March 2020

The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.117

31 March 2020

Regulatory T cells in tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of sphingosine kinase and sphingolipid signaling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discovery and evaluation of inhibitors of human sphingosine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/21912422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NRUROL.2011.117

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37930972&oldid=2201087716"